Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a realignment of its global business operations as part of ...
SAN DIEGO - Viracta Therapeutics, Inc. (NASDAQ: VIRX), a precision oncology company specializing in virus-related cancers, has announced it will terminate its employees and begin winding down ...